These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24687490)

  • 1. High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
    Eilertson B; Maruri F; Blackman A; Herrera M; Samuels DC; Sterling TR
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3270-5. PubMed ID: 24687490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
    Avalos E; Catanzaro D; Catanzaro A; Ganiats T; Brodine S; Alcaraz J; Rodwell T
    PLoS One; 2015; 10(3):e0120470. PubMed ID: 25816236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India.
    Chawla K; Kumar A; Shenoy VP; Chakrabarty S; Satyamoorthy K
    J Glob Antimicrob Resist; 2018 Jun; 13():250-253. PubMed ID: 29421317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
    J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Bernard C; Veziris N; Brossier F; Sougakoff W; Jarlier V; Robert J; Aubry A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1519-24. PubMed ID: 25534742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
    Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
    Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.
    Devasia R; Blackman A; Eden S; Li H; Maruri F; Shintani A; Alexander C; Kaiga A; Stratton CW; Warkentin J; Tang YW; Sterling TR
    J Clin Microbiol; 2012 Apr; 50(4):1390-6. PubMed ID: 22189117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
    Chaoui I; Oudghiri A; El Mzibri M
    J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR.
    van Doorn HR; An DD; de Jong MD; Lan NT; Hoa DV; Quy HT; Chau NV; Duy PM; Tho DQ; Chinh NT; Farrar JJ; Caws M
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):736-42. PubMed ID: 18544197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
    Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
    BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Specific
    Singh PK; Singh U; Jain A
    Microb Drug Resist; 2021 May; 27(5):647-651. PubMed ID: 32991238
    [No Abstract]   [Full Text] [Related]  

  • 13. Subpopulation analysis of heteroresistance to fluoroquinolone in Mycobacterium tuberculosis isolates from Beijing, China.
    Zhang X; Zhao B; Liu L; Zhu Y; Zhao Y; Jin Q
    J Clin Microbiol; 2012 Apr; 50(4):1471-4. PubMed ID: 22259208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
    Von Groll A; Martin A; Jureen P; Hoffner S; Vandamme P; Portaels F; Palomino JC; da Silva PA
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4498-500. PubMed ID: 19687244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.
    Singhal R; Reynolds PR; Marola JL; Epperson LE; Arora J; Sarin R; Myneedu VP; Strong M; Salfinger M
    J Clin Microbiol; 2016 Sep; 54(9):2298-305. PubMed ID: 27335153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
    Maruri F; Sterling TR; Kaiga AW; Blackman A; van der Heijden YF; Mayer C; Cambau E; Aubry A
    J Antimicrob Chemother; 2012 Apr; 67(4):819-31. PubMed ID: 22279180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of
    Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
    Malik S; Willby M; Sikes D; Tsodikov OV; Posey JE
    PLoS One; 2012; 7(6):e39754. PubMed ID: 22761889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospital.
    Soudani A; Hadjfredj S; Zribi M; Messaoud T; Masmoudi A; Majed B; Fendri C
    Clin Microbiol Infect; 2010 Sep; 16(9):1454-7. PubMed ID: 19845696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.